Perspective Therapeutics (CATX) Shares Outstanding (Entity) (2010 - 2026)
Perspective Therapeutics (CATX) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 1.73 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 383.57 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 576.60 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 377.40 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 451.69 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 977.43 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 97.50 Mn |
| 10 | Perspective Therapeutics | 387.28 Mn | 387.28 Mn | - | 114.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 114.15 Mn |
| Mar 31, 2026 | 114.02 Mn |
| Dec 31, 2025 | 74.34 Mn |
| Sep 30, 2025 | 74.34 Mn |
| Jun 30, 2025 | 74.26 Mn |
| Mar 31, 2025 | 74.05 Mn |
| Dec 31, 2024 | 70.67 Mn |
| Sep 30, 2024 | 67.56 Mn |
| Jun 30, 2024 | 67.43 Mn |
| Mar 31, 2024 | 58.69 Mn |
| Dec 31, 2023 | 28.18 Mn |
| Sep 30, 2023 | 28.06 Mn |
| Jun 30, 2023 | 28.05 Mn |
| Mar 31, 2023 | 22.86 Mn |
| Dec 31, 2022 | 14.21 Mn |
| Sep 30, 2022 | 14.21 Mn |
| Jun 30, 2022 | 14.20 Mn |
| Mar 31, 2022 | 14.20 Mn |
| Dec 31, 2021 | 14.20 Mn |
| Sep 30, 2021 | 14.19 Mn |